IMUGENE LIMITED — Major Shareholding Notification 2021

Sep 12, 2021

603 Page 1 of 3 15 July 2001

Form 603

Corporations Act 2001

Section 671B

Notice of initial substantial holder

To Company Name/Scheme Imugene Limited (ASX: IMU)

ACN/ARSN 009 179 551

1. Details of substantial holder (1)

Name

Paul Hopper

ACN/ARSN (if applicable)

The holder became a substantial holder on 09 / September / 2021

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

Class of securities (4)	Number of securities	Person's votes (5)	Voting power (6)
Fully Paid OrdinaryShares	291,196,435	291,196,435	5.4%

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holder of relevant interest	Nature of relevant interest (7)	Class and number of securities
Paul Alexander Hopper	Directly held.	2,358,900*
	Relevant interest under section
Moreglade Pty Limited	608(3) of the Corporations Act.	230,150,261*
	Relevant interest under section
Kilinwata Investments Pty Ltd	608(3) of the Corporations Act.	31,157,867*
	Relevant interest under section
Deborah Anne Coleman		27,529,407*
	608(1) of the Corporations Act.

*A total of 89,730,967 FPO Shares are subject to escrow for 12 months from the issue date, until 9 September 2022.

603 Page 2 of 3 15 July 2001

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Holder of relevant	Registered holder of	Person entitled to be	Class and number of securities
interest	securities	registered as holder (8)
Paul Alexander Hopper	Paul AlexanderHopper	Paul AlexanderHopper	2,358,900*
Moreglade Pty Limited	Moreglade PtyLimited	Moreglade PtyLimited	230,150,261*
Kilinwata Investments PtyLtd	KilinwataInvestments PtyLtd	KilinwataInvestments PtyLtd	31,157,867*
Deborah Anne Coleman	Deborah AnneColeman	Deborah AnneColeman	27,529,407*

*A total of 89,730,967 FPO Shares are subject to escrow for 12 months from the issue date, until 9 September 2022.

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

Holder of relevant	Date of	Consideration (9)	Consideration (9)	Class and number of securities
interest	acquisition
		Cash	Non-cash
Paul Alexander Hopper	09/09/2021	N/A	$0.0155	1,110,000*
Moreglade Pty Limited	25/05/2021	$0.0428	N/A	25,000,000
Moreglade Pty Limited	09/09/2021	N/A	$0.0155	83,094,838*
Deborah Anne Coleman	09/09/2021	N/A	$0.0155	5,526,129*

*A total of 89,730,967 FPO Shares are subject to escrow for 12 months from the issue date, until 9 September 2022.

6. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:

Name and ACN/ARSN (if applicable)	Nature of association
Moreglade Pty Limited	Associate under section 12(1) of the Corporations Act.
Kilinwata Investments PtyLtd	Associate under section 12(1) of the Corporations Act.
Deborah Anne Coleman	Associate under section 12(1) of the Corporations Act.

7. Addresses

The addresses of persons named in this form are as follows:

Name	Address
Paul Alexander Hopper	Suite 802 Level 8, 37 Bligh Street, SYDNEY NSW 2000
Moreglade Pty Limited	Suite 802 Level 8, 37 Bligh Street, SYDNEY NSW 2000
Kilinwata Investments PtyLtd	Suite 802 Level 8, 37 Bligh Street, SYDNEY NSW 2000
Deborah Anne Coleman	Suite 802 Level 8, 37 Bligh Street, SYDNEY NSW 2000

Signature

ure
print name	Paul Hopper	capacity	Paul Hopper Group
sign here		date	13/September/2021

603 Page 3 of 3 15 July 2001

DIRECTIONS

• (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7 of the form.

• (2) See the definition of "associate" in section 9 of the Corporations Act 2001.

• (3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

• (4) The voting shares of a company constitute one class unless divided into separate classes.

• (5) The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an associate has a relevant interest in.

• (6) The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.

• (7) Include details of:

  • (a) any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

  • (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

• (8) If the substantial holder is unable to determine the identity of the person ( eg. if the relevant interest arises because of an option) write "unknown".

• (9) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.